In vitro Effects of the Specific Mitochondrial TSPO Ligand Ro5 4864 in Cultured Human Osteoblasts

Abstract

The 18 kDa mitochondrial translocator protein (TSPO) ligands (10 µM), e. g., protoporphyrin IX, PK 11195 and FGIN-1-27, have different effects on metabolism and protein expression in human osteoblasts. In this study, we investigated the archetypical TSPO specific ligand Ro5-4864 (10 µM) effect in primary osteoblasts in culture aiming to further understand the TSPO role in these mature metabolically active cells.

We found that following exposure to Ro5-4864, cellular [¹⁸F]-FDG incorporation and ATP content were reduced by 48% (p<0.001) and 44% (p<0.001), respectively. The mitochondrial membrane potential (ΔΨm) increased by 50% (p<0.01), mRNA synthesis of TSPO and voltage dependent anion channel (VDAC1) decreased both by 70%, the TSPO and VDAC1 protein expression decreased by 80% and 68%, respectively (p<0.001). Ro5 4864 caused a decrease in the proportion of cells in the G1 phase (by 20%, p<0.05), shifting the cell cycle to the S and G2/M phases. Furthermore, 63% decrease in hexokinase 2 protein expression (p<0.001) was found. However, we found no significant effects on hexokinase 2 mRNA expression (by RT-PCR). We also did not see significant changes in mitochondrial mass (MitoTracker Green assay), apoptosis rate (TUNEL assay), overall cell death (LDH assay), cellular proliferation (BrdU assay), cell maturation (cellular alkaline phosphatase assay), and the number of cells in the culture.

Therefore, an overall effect of Ro5-4864 exhorts is via pathways related to the mitochondrial activity, which is only partly like PK 11195, but not to the other TSPO ligands.

Key words

Ro5-4864 - osteoblast-like cells - mitochondria - cell cycle - cell death - TSPO

• References

• 1 Veenman L, Papadopoulos V, Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO). Regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Design 2007; 13: 1-21
• 2 Zeno S, Veenman L, Katz Y. et al. The 18 kDa mitochondrial translocator protein (TSPO) prevents accumulation of protoporphyrin IX. Involvement of reactive oxygen species (ROS). Curr Molec Med 2012; 12: 494-501
• 3 Gavish M, Bachman I, Shoukrun R. et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 1999; 51: 629-650
• 4 Veenman L, Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther 2006; 110: 503-524
• 5 Caballero B, Veenman L, Bode J. et al. Concentration-dependent bimodal effect of specific 18 kDa translocator protein (TSPO) ligands on cell death processes induced by ammonium chloride: Potential implications for neuropathological effects due to hyperammonemia. CNS Neurol Disord Drug Targets 2014; 13: 574-592
• 6 Veenman L, Vainshtein A, Gavish M. TSPO as a target for treatments of diseases, including neuropathological disorders. Cell Death Dis 2015; 6: 294
• 7 Rosenberg N, Rosenberg O, Weizman A. et al. In vitro Mitochondrial Effects of PK 11195, a Synthetic Translocator Protein 18 kDa (TSPO) Ligand, in Human Osteoblast-like Cells. J Bioenerg and Biomembr 2011; 43: 739-746
• 8 Rosenberg N, Rosenberg O, Weizman A. et al. In vitro catabolic effect of protoporphyrin IX in human osteoblast-like cells: Possible role of the 18 kda mitochondrial translocator protein. J Bioenerg Biomembr 2013; 45: 333-341
• 9 Rosenberg N, Rosenberg O, Weizman A. et al. In vitro effect of FGIN-1-27, a ligand to 18 kDa mitochondrial translocator protein, in human osteoblast-like cells. J Bioenerg Biomembr 2014; 46: 197-204
• 10 Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: Biological role in steroidogenic cell function. Endocr Rev 1993; 14: 222-240
• 11 Lacapere JJ, Papadopoulus V. Peripheral type benzodiazepine receptor: Structure and function of a cholesterol – binding protein in steroid and bile acid biosynthesis. Science 2003; 68: 569-585
• 12 Garnier M, Boujrad N, Oke BO. et al. Diazapam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: Action via peripheral-type benzodiazepine receptor and independent mechanisms. Endocrinology 1993; 132: 444-458
• 13 Hardwick M, Fertikh D, Culty M. et al. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: Correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR- mediated cell proliferation and nuclear transport of cholesterol. Cancer Res 1999; 59: 831-842
• 14 Das SK, Sikpi MO, Skolnick P. Characterization of [3H]Ro5-4864 binding to “peripheral” benzodiazepine receptors in guinea pig alveolar type II cells. Biochem Pharmacol 1987; 36: 2221-2224
• 15 Akech J, Sinha Roy S, Das SK. Modulation of cholinephosphotransferase activity in breast cancer cell lines by Ro5-4864, a peripheral benzodiazepine receptor agonist. Biochem Biophys Res Commun 2005; 333: 35-41
• 16 Gundle R, Stewart K, Screen J. et al. Isolation and culture of human bone-derived cells. In: Beresford N, Owen ME. (ed.). Marrow stromal cell culture. Cambridge, UK: Cambridge University Press; 1998. pp 43-66
• 17 Yamanouchi K, Satomura K, Gotoh Y. et al. Bone formation by transplanted human osteoblasts cultured within collagen sponge with dexamethasone in vitro. J Bone Min Res 2001; 16: 857-867
• 18 Rosenberg N, Soudry M, Rosenberg O. et al. The role of activin A in the human osteoblast cell cycle: A preliminary experimental in vitro study. Exper Clin Endocr Diab 2010; 118: 708-712
• 19 Campana D, Coustan-Smith E, Janossy G. Double and triple staining methods for studying the proliferative activity of human B and T lymphoid cells. J Immunol 1988; 107: 79-88
• 20 Bortner CD, Oldenburg NB, Cidlowski JA. The role of DNA fragmentation in apoptosis. Trends Cell Biology 1995; 5: 21-26
• 21 Gay RB, Bowers Jr. GN. Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity. Clin Chem 1968; 14: 740-753
• 22 Rosenberg N, Bettman L, Rosenberg O. et al. Measurement of [¹⁸F]-fluorodeoxyglucose incorporation into human osteoblast–An experimental method. Cytotechnology 2007; 54: 1-4
• 23 Bessey OA, Lowry OH, Brock MJ. A method for the rapid determination of alkaline phosphatase with 5 cubic millimeters of serum. Journal of Biology and Chemistry 1946; 164: 321-329
• 24 Kugler W, Veenman L, Shandalov Y. et al. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine. Cell Oncol 2008; 30: 435-450
• 25 Oubrahim H, Stadtman ER, Chock BP. Mitochondria play no roles in Mn(II)-induced apoptosis in HeLa cells. Proc Nat Ac Sc USA. 2001; 98: 9505-9510
• 26 Stanley PE. A survey of more than 90 commercially available luminometers and imaging devices for low-light measurements of chemiluminescence and bioluminescence, including instruments for manual, automatic and specialized operation, for HPLC, LC, GLC and microtitre plates. Part 1: Descriptions. J Biolumin Chemilumin. 1992; 7: 77-108
• 27 Cossarizza A, Baccarani-Contri M, Kalashnikova G. et al. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Bioch Bioph Res Comm 1993; 197: 40-45
• 28 Veenman L, Alten J, Linnemannstöns K. et al. Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines. A mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein. Apoptosis 2010; 15: 753-768
• 29 Jaremko L, Jaremko M, Giller K. et al. Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science 2014; 343: 1363-1366
• 30 Li F, Liu J, Zheng Y. et al. Protein structure. Crystal structures of translocator protein (TSPO) and mutant mimic of a humanpolymorphism. Science 2015; 347: 555-558